Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ: MRNA )

34.46 -0.69 (-1.96%)
Official Closing Price Updated: 4:15 PM EST, Jan 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,427,289
Open 35.15
Bid (Size) 34.43 (1)
Ask (Size) 34.46 (2)
Prev. Close 35.15
Today's Range 33.18 - 35.68
52wk Range 31.94 - 170.47
Shares Outstanding 385,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell?
Shares hit another skid on Jan. 13 when the company cut its guidance for 2024 and 2025. 
Via Investor's Business Daily
Stocks Edge Down Ahead Of Key Inflation Reports, Crude Hits 5-Month High, Bitcoin Sinks: What's Driving Markets Monday?
Traders adopted a cautious approach on Monday as they awaited two critical inflation reports due later this week, seeking clarity on Federal Reserve interest rate policy. 
Via Benzinga
Topics Economy
Exposures Interest Rates

Performance

YTD
-17.95%
-17.95%
1 Month
-17.64%
-17.64%
3 Month
-39.87%
-39.87%
6 Month
-72.46%
-72.46%
1 Year
-66.27%
-66.27%

More News

Read More
Gold Down Over 1%; Salarius Pharmaceuticals Shares Surge
Via Benzinga
Moderna Stock Takes A 20% Hit
Via Talk Markets
Topics Stocks / Equities
Why Moderna Stock Just Crashed 21%
Via The Motley Fool
Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference
Via ACCESSWIRE
Spotlight on Moderna: Analyzing the Surge in Options Activity
Via Benzinga
Crude Oil Surges 3%; Abercrombie & Fitch Shares Plunge
Via Benzinga
Exposures Fossil Fuels
Moderna Stock Sinks To Over 5-Year Low On $1B Sales Guidance Cut: Retail’s Shaken
Via Stocktwits
Exposures COVID-19
Moderna Stock Crashes 21% After Covid Vaccine Maker Slashes 2024-25 Guidance
Via Investor's Business Daily
Exposures COVID-19
Moderna Expects Lower Annual Sales, Expands Cost-Cutting Initiatives
Via Benzinga
MarketBeat Week in Review – 01/06 - 01/10
Via MarketBeat
Topics Bonds Economy Government
Exposures Debt Markets Interest Rates Political
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today
Via Benzinga
10 Worst Performing Large-Caps Last 12 Months
Via Talk Markets
Topics Stocks / Equities
Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.
Via Investor's Business Daily
Topics Artificial Intelligence Government
Exposures Artificial Intelligence Political
"Motley Fool Money" 2025 Stock Market Preview
Via The Motley Fool
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Via Benzinga
Topics ETFs
Moderna Shares Spike on H5N1 News—What’s Next for Investors?
Via MarketBeat
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
Via The Motley Fool
Nvidia, Palantir, Ionq, Novavax, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
Topics Stocks
Exposures US Equities
Stocks Sink As Bond Yields Soar, Nvidia Eyes Worst Day In 4 Months, Bitcoin Tumbles To $97,000: What's Driving Markets Tuesday?
Via Benzinga
Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike
Via Investor's Business Daily
Exposures COVID-19
S&P 500, Nasdaq Fall As Economic Data, Bond Yields Weigh
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally
Via Benzinga
UniFirst, Getty Images, Shutterstock And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.